Key result
Intra-atrial infusion of tissue plasminogen activator (t-PA) resulted in complete or partial dissolution of chronic left atrial thrombi in 50% of treated patients within 48 hours.
Why the study?
Does intra-atrial thrombolytic therapy dissolve chronic left atrial thrombi in patients with mitral stenosis undergoing balloon mitral commissurotomy?
RCT (n=13)
Randomized into four groups
Does intra-atrial thrombolytic therapy dissolve chronic left atrial thrombi in patients with mitral stenosis undergoing balloon mitral commissurotomy?
Intra-atrial t-PA may have the potential to dissolve chronic left atrial thrombi in patients with mitral stenosis.
Answers are grounded in this paper and cite their sources.
May enable safer commissurotomy in mitral stenosis with LA thrombus; extends RCT evidence for targeted intra-atrial thrombolysis.
The purpose of this study was to evaluate the solubility of left atrial thrombi to thrombolytics after failure of long-term anticoagulant therapy in patient with mitral stenosis. One hundred and eighty-one consecutive patients with mitral valve area < or = 1.5 cm(2) and without severe mitral regurgitation were screened with echocardiography; 30 were found to have left atrial thrombi. Follow-up echocardiography performed 7.4 +/- 5.6 months after warfarin therapy revealed that 8/30 of patients had complete dissolution and 3/30 had partial dissolution of the thrombi. Thirteen patients with residual isolated appendageal thrombi underwent balloon mitral commissurotomy and were randomized into four groups at the end of balloon mitral commissurotomy: group A, receiving intra-atrial infusion of heparin and tissue plasminogen activator (t-PA; n = 4); group B, heparin and streptokinase (n = 3); group C, heparin (n = 3); and group D, acting as control (n = 3). It was found that only two patients in the t-PA group had their thrombi either completely or partially dissolved within 48 hr. Thus, this study suggests that t-PA may have the potential of dissolving chronic left atrial thrombi.
No takes yet. Share an insight, caveat, or question.
Chiang et al. (2002) conducted an RCT in Mitral stenosis with chronic left atrial thrombi (n=13). Intra-atrial tissue plasminogen activator (t-PA) and heparin vs. Heparin and streptokinase, heparin alone, or control was evaluated on Complete or partial dissolution of thrombi within 48 hours. Intra-atrial infusion of tissue plasminogen activator (t-PA) resulted in complete or partial dissolution of chronic left atrial thrombi in 50% of treated patients within 48 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: